A Chinese Version of the Thinking Health Program for East Asian Pregnant Immigrant People in Canada

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18+
SponsorQueen's University

About this trial

The goal of this study is to determine the feasibility of using a psychosocial intervention culturally adapted in China to support perinatal mental well-being of Chinese immigrant pregnant women in Canada. The intervention is adapted from the Thinking Healthy Program (THP), available through a mobile application, and will be offered to Chinese immigrant pregnant women (22 weeks' gestation or greater) residing in Canada, who are over the age of 18, and speak Mandarin. The main questions this study aims to answer are:

* Will the Chinese version of the THP be acceptable to Chinese immigrant pregnant women residing in Canada and will they use the program which is delivered through a mobile App? * How well does the process of recruiting, keeping participants in the study and helping them complete the activities work, so it can be used for a future larger study?

Women interested in the study and who meet the study criteria will complete a questionnaire at the start of the study, then use the THP for three weeks, complete questionnaires 3-4 weeks after completing the intervention and 6-8 weeks after having their baby(ies). Some may be asked to participate in an individual interview.

Eligibility criteria

Qualifiers

pregnant women at ≥ 22 weeks of gestation; AND

≥ 18 years old; AND

are first or second-generation Chinese immigrants residing in Canada (who identify as someone with East Asian cultural and ethnic background born outside of Canada or have at least one parent born outside of Canada); AND

understand both spoken and written Mandarin language; AND

Disqualifiers

Women currently being treated for mental conditions, including depression

Trial design

Treatments tested in this trial

  • THP: cognitive behavior therapy and behavioral activation

Treatment groups

50 Participants
are divided into 1 treatment group

Sponsors and collaborators